U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06880081) titled 'Study of PN20 in Adult Patients with Primary Immune Thrombocytopenia (ITP)' on March 11.
Brief Summary: The main aim of this clinical trial is to assess the safety and tolerability of PN20 in adult patients with primary immune thrombocytopenia (ITP). The main questions it aims to answer are:
* Is PN20 safe in these patients?
* Could these patients potentially benefit from PN20 treatment?
Participants will
* Receive one subcutaneous injection of PN20 according to weight;
* Visit the clinic for assessment.
Study Start Date: March 07
Study Type: INTERVENTIONAL
Condition:
Primary Immune Thrombocytopenia (ITP)
Intervention:
D...